SLC2A1 and Alzheimer disease: These data are in agreement with a study demonstrating that HIF-1 levels are reduced in AD brains compared to age-matched controls [18], resulting in decreased GLUT1 and GLUT3 levels and with abnormal tau hyperphosphorylation [3].